Skip to main content

Fulcrum Therapeutics, Inc.

FULC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001680581

No open-market purchases or sales by Fulcrum Therapeutics, Inc. insiders were filed in the last 90 days; 150 institutions reported holding it in 13F filings for Q3 2026, worth $290.2M in total; no superinvestor holds it.

Holders of 5% or more of FULC

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Fulcrum Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of FULC
HolderLatest formStakeChangeFirst filedLatest filingFiling
Tang Capital Management LLC13G/A10.40%6.91M shares+2.20 ppfrom 8.20%Jun 10, 20262 filingsJul 15, 2026SEC
EcoR1 Capital, LLC13G/A8.90%6.80M shares−0.10 ppfrom 9.00%Jun 25, 20263 filingsNov 16, 2026SEC
ADAR1 Capital Management, LLC13G8.70%6.65M sharesNewNov 16, 20261 filingNov 16, 2026SEC
Nantahala Capital Management, LLC13G/A8.62%6.58M shares+0.40 ppfrom 8.22%Nov 14, 20244 filingsNov 13, 2026SEC
BlackRock Portfolio Management LLC13G/A8.10%6.16M shares+2.10 ppfrom 6.00%Jul 17, 20262 filingsOct 27, 2026SEC
BlackRock, Inc.13G/A7.20%4.80M shares+1.20 ppfrom 6.00%Oct 21, 20246 filingsJul 28, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

75 Schedule 13D and 13G filings on Fulcrum Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on FULC
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 16, 20269:39 PM ETADAR1 Capital Management, LLCand 1 other13G8.70%6.65M sharesNewSep 30, 2026SEC
Nov 16, 20262:22 PM ETEcoR1 Capital, LLCand 2 others13G/A8.90%6.80M shares−0.10 ppfrom 9.00%Sep 30, 2026SEC
Nov 13, 20265:06 PM ETNantahala Capital Management, LLCand 2 others13G/A8.62%6.58M shares+0.40 ppfrom 8.22%Sep 30, 2026SEC
Nov 13, 20264:04 PM ETSuvretta Capital Management, LLCand 2 others13G/A0.00%0 shares−5.50 ppfrom 5.50%Below 5%Sep 30, 2026SEC
Oct 28, 20261:57 PM ETBank of America Corp13G/A1.50%1.11M shares−5.20 ppfrom 6.70%Below 5%Sep 30, 2026SEC
Oct 27, 20264:09 PM ETBlackRock Portfolio Management LLC13G/A8.10%6.16M shares+2.10 ppfrom 6.00%Sep 30, 2026SEC
Aug 14, 20264:42 PM ETRa Capital Management, L.P.and 3 others13G/A0.00%0 shares−9.90 ppfrom 9.90%Below 5%Jun 30, 2026SEC
Aug 14, 20264:38 PM ETNantahala Capital Management, LLCand 2 others13G8.22%5.48M shares+3.64 ppfrom 4.58%Jun 30, 2026SEC
Aug 14, 20264:22 PM ETSuvretta Capital Management, LLCand 2 others13G/A5.50%3.68M shares−3.90 ppfrom 9.40%Jun 30, 2026SEC
Aug 14, 20264:20 PM ETTCG Crossover GP II, LLCand 2 others13G/A0.00%0 shares−7.90 ppfrom 7.90%Below 5%Jun 30, 2026SEC
Aug 3, 202612:12 PM ETBank of America Corp13G6.70%4.47M sharesNewJun 30, 2026SEC
Jul 28, 20264:44 PM ETBlackRock, Inc.13G/A7.20%4.80M shares+1.20 ppfrom 6.00%Jun 30, 2026SEC
Jul 17, 202611:33 AM ETBlackRock Portfolio Management LLC13G6.00%4.02M sharesNewJun 30, 2026SEC
Jul 15, 20267:53 PM ETTang Capital Management LLCand 5 others13G/A10.40%6.91M shares+2.20 ppfrom 8.20%Jul 13, 2026SEC
Jun 25, 20266:10 PM ETEcoR1 Capital, LLCand 2 others13G9.00%6.00M shares0.00 ppfrom 9.00%Jun 17, 2026SEC
Jun 25, 20265:51 PM ETEcoR1 Capital, LLCand 2 others13G9.00%6.00M sharesNewJun 17, 2026SEC
Jun 10, 20266:13 PM ETTang Capital Management LLCand 5 others13G8.20%5.45M sharesNewJun 3, 2026SEC
May 15, 20264:36 PM ETNantahala Capital Management, LLCand 2 others13G/A4.58%3.05M shares−3.08 ppfrom 7.66%Below 5%Mar 31, 2026SEC
May 15, 20264:26 PM ETTCG Crossover GP II, LLCand 2 others13G/A7.90%5.25M shares–Mar 31, 2026SEC
Mar 26, 20266:37 PM ETVanguard Group Inc13G/A0.00%0 shares–Below 5%Mar 13, 2026SEC
Feb 17, 20264:29 PM ETRa Capital Management, L.P.and 3 others13G/A9.90%6.65M shares−1.30 ppfrom 11.20%Dec 31, 2025SEC
Dec 10, 20254:44 PM ETRa Capital Management, L.P.and 3 others13G/A11.20%6.05M shares–Dec 8, 2025SEC
Nov 13, 20259:03 AM ETAdage Capital Management, L.P.and 2 others13G/A4.50%2.43M shares−4.00 ppfrom 8.50%Below 5%Sep 30, 2025SEC
Oct 17, 20256:40 PM ETBlackRock, Inc.13G/A6.00%3.27M shares−1.50 ppfrom 7.50%Sep 30, 2025SEC
Aug 12, 20259:01 AM ETAdage Capital Management, L.P.and 2 others13G/A8.50%4.59M shares+2.94 ppfrom 5.56%Jun 30, 2025SEC
May 2, 20255:33 PM ETSuvretta Capital Management, LLCand 2 others13G/A9.40%5.07M shares+3.10 ppfrom 6.30%Mar 31, 2025SEC
Apr 17, 20259:35 AM ETBlackRock, Inc.13G/A7.50%4.03M shares–Mar 31, 2025SEC
Feb 12, 20259:32 AM ETAdage Capital Management, L.P.and 2 others13G5.56%3.00M sharesNewDec 31, 2024SEC
Jan 6, 20254:50 PM ETSuvretta Capital Management, LLCand 2 others13G6.30%3.40M shares–Dec 27, 2024SEC
Dec 6, 2024BlackRock, Inc.13GOld format–––SEC
Nov 14, 20244:53 PM ETNantahala Capital Management, LLCand 2 others13G7.66%4.78M sharesNewSep 30, 2024SEC
Nov 14, 2024Suvretta Capital Management, LLC13G/AOld format–––SEC
Nov 14, 2024RTW Investments, LP13G/AOld format–––SEC
Nov 12, 2024Vanguard Group Inc13G/AOld format–––SEC
Nov 8, 2024BlackRock, Inc.13GOld format–––SEC
Nov 4, 2024Vanguard Group Inc13G/AOld format–––SEC
Oct 21, 2024BlackRock, Inc.13GOld format–New–SEC
Oct 7, 2024FMR LLC13G/AOld format–––SEC
Sep 20, 2024TCG Crossover GP II, LLC13GOld format–New–SEC
Sep 16, 2024Ra Capital Management, L.P.13G/AOld format–––SEC
Aug 23, 2024Ra Capital Management, L.P.13G/AOld format–––SEC
Feb 14, 2024Third Rock Ventures III, L.P.13G/AOld format–––SEC
Feb 14, 2024Ra Capital Management, L.P.13G/AOld format–––SEC
Feb 14, 2024RTW Investments, LP13G/AOld format–––SEC
Feb 13, 2024Suvretta Capital Management, LLC13G/AOld format–––SEC
Feb 9, 2024FMR LLC13G/AOld format–––SEC
Feb 7, 2024Adage Capital Partners GP, L.L.C.13G/AOld format–––SEC
Jul 7, 20234:35 PM ETBlackRock Inc.13G/AOld format–––SEC
Mar 6, 2023Adage Capital Partners GP, L.L.C.13GOld format–––SEC
Feb 14, 2023Third Rock Ventures III, L.P.13G/AOld format–––SEC

Form 144: proposed insider sales

6 notices from officers, directors and other affiliates planning to sell Fulcrum Therapeutics, Inc. shares, newest first.

Form 144 notices for FULC
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Sep 2, 20269:30 AM ETGreg TourangeauFormer officer14.1K$54.4KSep 2, 2026Merrill Lynch, Pierce, Fenner & Smith IncSEC
Jun 26, 20264:26 PM ETAlan EzekowitzDirector18.0K$65.0KJun 26, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Dec 15, 20254:32 PM ETCurtis G OltmansOfficer3.45K$44.9KDec 15, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Dec 8, 20255:40 PM ETRA Capital Healthcare Fund LP10% stockholder4.18M$54.2MDec 8, 2025BTIG, LLCSEC
Nov 19, 20254:20 PM ETRobert J GouldDirector45.0K$437.9KNov 19, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Mar 8, 20246:00 PM ETGreg TourangeauOfficer4.88K$57.2KMar 8, 2024Merrill Lynch, Pierce, Fenner & Smith IncSEC